• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity

tetano

Editor, Senior Moderator
Immunogenetics. 2017 Aug 25. doi: 10.1007/s00251-017-1026-2. [Epub ahead of print]
[h=1]Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.[/h] David S[SUP]1,[/SUP][SUP]2[/SUP], Correia V[SUP]3[/SUP], Antunes L[SUP]4[/SUP], Faria R[SUP]5[/SUP], Ferr?o J[SUP]5[/SUP], Faustino P[SUP]5,[/SUP][SUP]6[/SUP], Nunes B[SUP]4[/SUP], Maltez F[SUP]7[/SUP], Lavinha J[SUP]5,[/SUP][SUP]8[/SUP], de Andrade HR[SUP]3,[/SUP][SUP]9[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza epidemics are a serious global public health and economic problem. The IFITM3 allele (rs12252-C) was suggested as a population-based genetic risk factor for severe influenza virus infection by A(H1N1)pdm09. We analyzed the population genetics of IFITM3 variants in the Portuguese general population (n = 200) and Central Africans (largely Angolan) (n = 148) as well as its association to influenza severity in Portuguese patients (n = 41). Seven SNPs, within the 352 bp IFITM3 amplicon around rs12252, were identified. SNP distributions in the Portuguese appeared at an intermediate level between the Africans and other Europeans. According to HapMap, rs34481144 belongs to the same linkage disequilibrium (LD) block as rs12252 and is in strong LD with rs6421983. A negative association with severe relative to mild disease was observed for allele rs34481144-A, indicating a protective effect under the dominant model. Moreover, haplotype Hap4 with rs34481144-A, not including rs12252-C, was significantly associated to mild influenza. Conversely, although with borderline significance, haplotype Hap1 with rs34481144-G, not including rs12252-C, was associated to severe disease. Moreover, in comparison to the general Portuguese population, statistical significant differences in the frequencies of the protective allele rs34481144-A in the severe disease group, the deleterious Hap1 in the mild disease group, and the protective Hap4 in the severe disease group were observed. The population attributable risk (PAR) for the targeted rs34481144 allele or genotype was of 55.91 and 64.44% in the general population and the mildly infected individuals, respectively. Implication of these variants in disease phenotype needs further validation, namely through functional analysis as is discussed.


[h=4]KEYWORDS:[/h] Central Africa; IFITM3 gene; Influenza virus; Population genetics; Portugal

PMID: 28842783 DOI: 10.1007/s00251-017-1026-2
 
Back
Top Bottom